OxyPrem
Z├╝rich · Founded 2018
About OxyPrem
OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants. The company develops, designs, and manufactures sensor solutions for monitoring of preterm infants. It is a reusable device that offers better clinical care due to its high quality, while substantially reducing waste. OxyPrem uses harmless light (more on NIRS) to determine absolute hemoglobin oxygen saturation in any human tissue. It helps them to prevent early death and severe long-term brain damage to this most vulnerable group of patients.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.7M
- Last round: Equity Crowdfunding (Aug 2024)
- Website: http://www.oxyprem.com/
- Phone: +41 43 508 16 97
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/oxyprem-61366 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.